UnknownNot applicableNCT04483011
The Safety and Efficacy Study of RiaGev in Healthy Adults
Studying Premature aging
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bioenergy Life Science, Inc.
- Principal Investigator
- Malkanthi Evans, Ph.DKGK Science Inc.
- Intervention
- RiaGev(dietary_supplement)
- Enrollment
- 18 enrolled
- Eligibility
- 36-65 years · All sexes
- Timeline
- 2019 – 2020
Study locations (1)
- Prism Research, Inc., Saint Paul, Minnesota, United States
Collaborators
KGK Science Inc. · University of Washington
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04483011 on ClinicalTrials.govOther trials for Premature aging
Additional recruiting or active studies for the same condition.